Clinical Trial: A Clinical Study of HH-1270 in Healthy Chinese Subjects

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07876440) titled 'A Clinical Study of HH-1270 in Healthy Chinese Subjects' on Oct. 09.

Brief Summary: This study is a single-center, randomized, double-blind, placebo-controlled, single ascending dose (SAD) and multiple ascending dose (MAD) clinical trial to evaluate the safety and PK profile in healthy Chinese subjects.

Study Start Date: Oct. 19

Study Type: INTERVENTIONAL

Condition: Chronic HDV Infection

Intervention: DRUG: HH-1270

SAD groups will be received HH-1270 tablets from 5mg to 200mg once and MAD groups will be received HH-1270 tablets from 5 mg to 60 mg once per day for 7 days

DRUG: placebo

SAD groups will be received placebo tabl...